Regeneron Study Site — Atlanta, Georgia

Regeneron Study Site is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Regeneron Study Site has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Atopic Dermatitis, COVID-19, Eosinophilic Esophagitis (EoE).

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Study Site?

Regeneron Study Site has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Study Site conducted?

Regeneron Study Site has 14 clinical trials on record, with 1 currently active. Their work covers Atopic Dermatitis, COVID-19, Eosinophilic Esophagitis (EoE).

Is Regeneron Study Site accredited by Crixeo Health?

Regeneron Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.